703-33-3

Basic information

• Product Name: 5,8-dichloropyrido[2,3-d]pyridazine
• Synonyms: 5,8-dichloropyrido[2,3-d]pyridazine;5,8-Dichloropyrido[3,2-d]pyridazine;1,4-Dichloro-5-azaphthalazine;NSC 131225
• CAS NO: 703-33-3
• Molecular Formula: C₇H₃Cl₂N₃
• Molecular Weight: 200.03
• Mol File: 703-33-3.mol
• Article Data: 9

Chemical Properties

• Melting Point: 169℃
• Boiling Point: 419.5ºC at 760 mmHg
• Flash Point: 240ºC
• Appearance: /
• Density: 1.573g/cm3
• Vapor Pressure: 7.37E-07mmHg at 25°C
• Refractive Index: 1.682
• PKA: -0.19±0.30(Predicted)
• CAS DataBase Reference: 5,8-dichloropyrido[2,3-d]pyridazine(CAS DataBase Reference)
• NIST Chemistry Reference: 5,8-dichloropyrido[2,3-d]pyridazine(703-33-3)
• EPA Substance Registry System: 5,8-dichloropyrido[2,3-d]pyridazine(703-33-3)

Safety Data

• Hazardous Substances Data: 703-33-3(Hazardous Substances Data)

Usage

General Description

5,8-Dichloropyrido[2,3-d]pyridazine is a chemical compound that typically comes in a crystalline form. As the name suggests, it is a pyridazine compound, which is a class of organic chemicals that contain a six-membered ring with two nitrogen atoms. Apart from its usual appearance, little is known about its physical properties or potential applications. Safety information is also lacking, emphasizing the need for careful handling and use in controlled environments. Due to this, it's largely used in research contexts and there is scarce information about its medicinal properties or industrial applications. The compound can be identified via its CAS number, 207205-33-4.

InChI:InChI=1/C7H3Cl2N3/c8-6-4-2-1-3-10-5(4)7(9)12-11-6/h1-3H

Upstream product

• 4430-77-7 pyrido[2,3-d]pyridazine-5,8(6H,7H)dione 
• 4430-77-7 6,7-dihydropyrido[2,3-d]pyridazine-5,8-dione 
• 699-98-9 Pyridine-2,3-dicarboxylic anhydride 

Downstream Products

• 2942-32-7 6-Chloro-1,2,4-triazolo<4,3-b>pyrido<2,3-d>pyridazine 
• 23590-60-5 8-chloro-6H-pyrido[2,3-d]pyridazin-5-one 
• 23590-61-6 5-chloro-7H-pyrido[2,3-d]pyridazin-8-one 
• 81214-63-3 8-aminopyrido<2,3-d>pyridazine-5(6H)-one 
• 81214-61-1 5-chloro-7-acetylpyrido<2,3-d>pyridazine-8(7H)-one 
• 1133750-26-1 (R)-(4-(8-chloropyrido[3,2-d]pyridazin-5-yl)-3-methylpiperazin-1-yl)(phenyl)methanone 
• 1133750-24-9 (R)-(4-(5-chloropyrido[2,3-d]pyridazin-8-yl)-3-methylpiperazin-1-yl)(phenyl)methanone 
• 1365803-37-7 8-chloro-N-(3-(trifluoromethyl)phenyl)pyrido[2,3-d]pyridazin-5-amine 
• 1365803-36-6 5-chloro-N-(3-(trifluoromethyl)phenyl)pyrido[3,2-d]pyridazin-8-amine 
• 1365802-43-2 methyl 4-(5-{[3-(trifluoromethyl)phenyl]amino}pyrido[2,3-d]pyridazin-8-yl)benzoate 

Relevant articles and documents

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.

Addressing PXR liabilities of phthalazine-based hedgehog/smoothened antagonists using novel pyridopyridazines

Pyridopyridazine antagonists of the hedgehog signaling pathway are described. Designed to optimize our previously described phthalazine smoothened antagonists, a representative compound eliminates a PXR liability while retaining potency and in vitro metab